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1. Introduction 
The discovery of penicillin by Alexander Fleming in 1928 was a turning point which 
fundamentally revolutionized human and veterinary medicine. Antibiotics in veterinary 
medicine have been used to prevent and control bacterial infections and as growth 
promoters. Prevention and control of bacterial infections have been achieved by a 
therapeutic, metaphylactic or prophylactic application of antibiotics. Therefore, the 
substances, predominantly of the same class as in human medicine, have been used in 
veterinary medicine. Antibiotics regularly administered to animals in order to improve their  
growth, to better the use of feed and to reduce the number of falls have been defined as 
antibiotic growth promoters. The use of AGP in the European Union was approved by the 
Council Directive of 23 November 1970 concerning feed additives  (70/524/EEC). 
 
 
Fig. 1. Routes of spread of antibiotic-resistant strains of bacteria and drug resistance genes  
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The use of additives in feed has caused a number of negative changes. It influenced, among 
others, the environmental degradation and development of drug resistance in bacteria. 
Livestock are a major reservoir of bacteria resistant to antibiotics. These pathogens 
contained in animal meet entered human body and quickly spread in human society. 
Resistant bacteria also spread thanks to the use of manure as natural fertilizer. Such 
fertilizer, rich in drug-resistant bacteria, contaminated water and soil which had direct 
contact with grown plants presenting food both for humans and animals. The routs of 
spreading of antibiotic-resistant strains of bacteria are shown in Figure 1 (Witte, 2000).  
For this reason, the number of kinds of antibiotics approved for use in animal nutrition have 
been consistently limited. 
Beginning from 1 January 2006, the European Union introduced a total ban on the 
application of antibiotic growth promoters in feeds for animals bred for consumption. The 
ban was introduced at the same time in all countries of the Union. Since that time, 
antibiotics have been allowed to be used as drugs only in medicinal animal feeds or in 
prophylactic additives. The Regulation EC No 1831/2003 of the European Parliament and 
Council dated 22 August 2003, on the additives used in animal nutrition, includes, among 
others, probiotics as feed additives alternative to antibiotic growth promoters (Casewell et 
al. 2003; Berghmann et al., 2005).  
2. Definition of the term “probiotic”  
It is most probable that it was Ferdinand Vergin who introduced the term “probiotic” in 
1954, when, in an article entitled “Anti und Probiotika” he compared the detrimental effect 
exerted on the flora by antibiotics and other antimicrobial substances with positive impact 
(„Probiotika”) induced by beneficial bacteria. A few years later, in 1965, Lilly & Stillwell 
described probiotics as microorganisms stimulating the growth of other microorganisms. In 
1974, Parker used this term for organisms and substances that contribute to balancing the 
intestinal microflora of the host. The definition currently in use was proposed by 
FAO/WHO in 2002. It defines probiotics as live microorganisms which when administered 
in adequate amounts provide health benefits to the host. The microorganisms used in 
animal nutrition in the European Union include mainly Gram-positive bacteria that belong 
to the genus Bacillus (B. cereus, B. licheniformis, B. subtilis), Enterococcus (E. faecium), 
Lactobacillus (L. acidophilus, L. casei, L. farciminis, L. plantarum, L. rhamnosus), Pediococcus (P. 
acidilactici), Streptococcus (S. infantarius), and yeasts of the genus Saccharomyces (S. cerevisiae 
and S. boulardii) (Anadόn et al., 2006). Saccharomyces boulardii is a non-pathogenic yeast 
described in clinical literature as a biotherapeutical factor. According to taxonomic research, 
S. boulardii is considered to be a variation within the species S. cerevisiae, and in accordance 
with the agreed taxonomy it should be referred to as S. cerevisiae var. boulardii (Mitterdorfer 
et al., 2002; Van der Kühle, 2005). In contrast to bacteria of the genus Bacillus and yeasts of 
the genus Saccharomyces, Lactobacillus and Enterococcus bacteria belong to typical intestinal 
animal microflora and are present in large quantities, i.e.  respectively 107–108 and 105–106 
CFU/g in the intestinal content (Anadόn et al., 2006). 
3. Procedures of probiotics evaluation 
According to the Commission Directive 94/40/EC of 22 July 1994 setting out procedures for 
the assessment of additives, including microorganisms used in animal nutrition, results 
should be presented concerning mainly the following areas:  
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1. Identification, characteristics, conditions of use and methods of control of the additive 
In case of microorganisms it is necessary to provide:  
 name and taxonomic description in accordance with the International Code of 
Nomenclature 
 name and place of culture collection and number of deposit  
 genetic modification and all relevant characteristics for its identification 
 origin 
 genetic stability and purity of the cultivated strains 
 properties relevant for the identification and proposed usage (e.g. vegetative form or 
sporulated form, CFU/g) 
 resistance (loss of biological activity, e.g. viability): to weather activity (storage 
duration), during the preparation of premixes and feed (possible degradation 
products), to storage of premixes and feed in certain defined conditions (storage 
duration). 
2. Effectiveness of the additive  
In case of microorganisms it is necessary to provide:  
 information about the effects on: the nutritional value, the growth of animals, animal 
product features and their effectiveness, animal welfare and other parameters having  a 
positive impact on animal production  
 conditions for conducting experiments on animals. The test performed must be 
described, along with the statistical assessment and the methods used. The description 
must include the following data: 
 species, breed, age and sex of animals (the method of identification) 
 the test number and the number of experimental groups together with the number of 
animals in each of them 
 the level of content of microorganism(s) in feed established by a control analysis with 
the use of a relevant approved method 
 the place where the test was carried out, together with the description of health, 
physiological, nutritional and breeding conditions in accordance with the standard 
practice in the Community 
 the date and exact duration of testing  
 side effects and other negative effects which occurred during the experiment and the 
time when they were observed. 
3. Additive safety. 
In case of microorganisms it is necessary to: 
 demonstrate the lack of pathogenicity and toxicity in relation to the target species and 
humans under the anticipated conditions of use 
 identify the antibiotic resistance  
 present the results of tolerance tests in the target species. In the case of genetically 
modified organisms (GMO), in the understanding of Article 2 item 1 and 2 of Council 
Directive 90/220/EEC, the following information must be provided: 
 a copy of the written consent of the competent authorities to the deliberate release of 
genetically modified organisms for the sake of research and development in accordance 
with Article 6 item 4 of Directive 90/220/EEC, and a summary of the notification, as 
specified in Article 9 of Directive 90/220/EEC 
 complete technical documentation with information required in Annex 2 to Directive 
90/220/EEC, extended, if necessary, with the data on the variety of use of the additive, 
including the information on the data and results obtained based on the releases of 
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GMOs, conducted for the sake of research and development and concerning ecosystems 
that might be affected by the use of the additive, and also a risk assessment in respect of 
human and animal health and the environment in connection with the genetically freed 
organism contained in the product, including the information obtained from the current 
stage of research and development concerning the influence of the GMO release on 
human health and the environment. 
 conditions of introducing the additive on the market, including special conditions of 
use and transport, as well as a proposal for labeling and packaging, which should at 
least comprise the requirements set out in Annex III to Directive 90/220/EEC 
4. Activity of probiotic microorganisms 
The mechanism of the impact of probiotics on animals has not been fully elucidated and is 
still under investigation. According to the literature data, the proposed operation 
mechanisms of probiotic strains are as follows: 
4.1 Maintenance of microbiological balance in alimentary tract 
Maintenance of microbiological balance, the so-called eubiosis in the alimentary tract. The 
alimentary tract of animals immediately after birth is sterile and susceptible to colonization 
by various microorganisms, including also the pathogenic ones of the coli group, or of the 
genus Salmonella. Probiotic strains compete with pathogenic microorganisms for adhesion 
and colonization of biological membranes (Nousiainen et al., 2004). While adhering, 
probiotic bacteria form thin durable layers known as biofilm. Biofilm is composed of 
bacteria only in a small part. The remainder comprises exopolymers of these bacteria that 
form the so-called matrix. These include polysaccharides, proteins, nucleic acids and 
phospholipids. The release of these compounds is the result of adaptation to the 
environment. Exopolymers affect the biological, physical and chemical characteristics of the 
biological membrane and form its essential element. Polysaccharide exopolymers maintain 
the biofilm in the shape of a whole, as they fill the gaps formed among microorganisms. 
Usually biofilm contains 4 times more polysaccharide exopolymers than proteins. In the 
early stages of biofilm formation these are the polisaccharides that are released with the 
greatest intensity. They help the first cells to attach to the surface. Other exopolymers 
secreted by cells are proteins. Initially, proteins are gathered on the surface of the cells, and 
later, when they are released, they associate on the target surface, which helps to keep the 
cells on the surface. Proteins are usually a mixture of collagen and elastin. They form the 
extracellural matrix to which microorganisms adhere (Czaczyk, 2003).  
In the control of intestinal microflora an important role is played by metabolites of lactic 
acid bacteria with antagonistic activity. Among the compounds that inhibit the growth of 
pathogenic microorganisms, the ones considered to be the most important are organic acids, 
especially lactic acid and acetic acid, as well as hydrogen peroxide and bacteriocins 
(Salminen et al., 1998; Saarela et al., 2000; Mercenier et al., 2003). Antibacterial effect of 
organic acids is due to a rapid reduction in pH values beyond the optimum value range for 
the growth of most microorganisms, i.e. 6-7, as well as the inhibition of biochemical activity 
of microorganisms by undissociated acid molecules (Boris & Barbés, 2000; Messens & de 
Vuyst, 2002). Weak acids (lactic and acetic acid) as lipophilic compounds in the 
undissociated form pass into the cytoplasm, where they dissociate, which results in the 
reduction of pH inside the cell and the disruption of the process of moving protons through 
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the outer membrane and the increase in its tension. This in turn is manifested by an increase 
in the permeability. They can also cause denaturation of proteins (Ekuland, 1989; Caplice & 
Fitzgerald, 1999). The effect of lactic acid on the permeability of the outer membrane of 
Escherichia coli, Pseudomonas aeruginosa, Salmonella Typhimurium was examined by Alakomi 
et al., (2000). These researchers observed that even 5mM of lactic acid (pH 4.0) resulted in a 
significant increase in the permeability of the outer membrane in case of each of the strains 
studied by them, and the effect of lactic acid was even stronger than the effect of EDTA or 
HCl. The dissociation constant of lactic acid is 3.08, and in case of acetic acid it equals 4.87. 
Acetic acid, due to higher pKa, shows stronger antimicrobial activity than lactic acid 
(Cherrington et al., 1991). According to Eklund (1983), the reduction of pH of the 
environment to 4.0 leads to the situation where the undissociated form of acetic acid equals 
85%, and in case of lactic acid it constitutes only 11%. Acetic acid is a potent inhibitor of the 
growth of bacteria, yeasts and molds (Blom & Mörtvedt, 1991). Ray (1992), showed that in 
an environment with pH of 5.0 in 1% solution of acetic acid there are enough undissociated 
molecules to inhibit the growth of Gram-positive and Gram-negative bacteria, while in 1% 
solution of lactic acid the number of undissociated molecules is enough only to inhibit 
Gram-negative bacteria. Thus, during the fermentation with facultative heterofermentative 
strains of LAB, lactic acid is mainly responsible for lowering pH of the environment, while 
the acetic acid acts as an antimicrobial factor (Ouwehand & Vesterlund, 2004). It should be 
noted, however, that lactic acid not only lowers pH, but also functions as a factor causing 
increased permeability of the outer membrane of Gram-negative bacteria, and thus it may 
increase the effectiveness of other antagonistic substances (Alakomi et al., 2000).  
 Lactobacillus, and some other lactic acid-producing bacteria, in the absence of heme, do not 
use the cytochrome system (which reduces oxygen to water) for the final oxidation. These 
bacteria use flavoproteins that convert oxygen into hydrogen peroxide. The production of 
hydrogen peroxide is catalyzed by different enzyme systems present in the cells of lactic 
acid bacteria, namely the pyruvate oxidase, L-lactate oxidase, superoxide dismutase, D-
lactate dehydrogenase and NADH oxidase. Hydrogen peroxide is a well-known 
antibacterial substance. The activity of H2O2  results from strong oxidizing properties. 
Hydrogen peroxide may inhibit the growth or kill other microbes that do not possess or 
have low levels of enzymes degrading H2O2, such as catalase and peroxidase. Studies 
conducted in vitro confirm the inhibition of different bacteria such as: Staphylococcus aureus, 
Salmonella Typhimurium, Escherichia coli, Clostridium perfringens, Clostridium butyricum and 
Pseudomonas sp. by hydrogen peroxide (Dembele et al., 1998; Tomas et al., 2004). 
Bacteriocins are protein substances produced by numerous strains of lactic acid bacteria and 
propionic acid bacteria. They make a highly diversified group of compounds in terms of 
physical and biochemical properties. Bakteriocins have a bactericidal or bacteriostatic effect. 
They attack the cell membranes of microorganisms possessing receptors capable of bonding 
to them. These receptors are used for the translocation of bacteriocins and other compounds 
across the cytoplasmatic membrane. Their construction and properties are not fully known 
yet. Bacteriocins may cause: poration of bacterial cytoplasmatic membrane, which leads to 
the dispersal of the transmembrane potential and induces leakage of K+ ions, ATP and 
amino acids from the cytoplasm of affected cells; cell lysis; and they may also interfere with 
or inhibit the synthesis of DNA, RNA and proteins (acting as DNA-zy lub RNA-zy) 
(Daeschel, 1989; Klaenhammer, 1993; Grajek & Sip, 2004). Bacteriocynogenic microbes are 
resistant to the effect of bacteriocins produced by them. Some bacteriocins of lactic acid 
bacteria are active against pathogens in food, such as, for example Listeria monocytogenes, 
others inhibit the growth of Gram-positive aerobic and anaerobic bacteria of the genera 
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Bacillus and Clostridium (Schillinger & Holzapfel, 1996). Yeasts of the genus Saccharomyces 
are characterized by a high content of glucan and mannan in the cell wall and, therefore, 
may show an affinity to specific bacterial adhesins. Mannans have a high affinity to fimbrial 
structures (lectins) specific for mannose binding type 1 in pathogenic bacteria, such as 
Escherichia coli or Salmonella sp. They place themselves in the „hook”, i.e. in the area where 
those undesirable microorganisms adhere to the receptors of epithelial structures of the 
digestive system. Then, pathogenic bacteria lose the ability to adhere to the epithelial surface 
and thus, given the structure of the mannan which is not digested by the endoenzymatic 
system of animals, they are passaged (transported) along the axis of the intestinal tract and 
excreted with the feces of birds. Studies have demonstrated adherence of E. coli to the cells 
of Saccharomyces cerevisiae var. boulardii, and  agglutination was similar to that observed 
between E. coli and erythrocytes, phagocytes and epithelial cells (Gedek, 1999). As 
demonstrated by the in vitro and in vivo research, yeasts exert inhibitory effects on Salmonella 
Typhi, Salmonella Typhimurium, Staphylococcus aureus, Pseudomonas aeruginosa, Shigella 
atypical, Escherichia coli, Clostridium difficile, Klebsiella sp., Yersinia enterocolitica, Candida 
albicans, Candida pulcherrima, Candida kruzei, Candida pseudotropicalis, Torulopsis gropengiesseri 
(Tasteyre et al., 2002; Van der Aa Kühle et al., 2005).  
At the current stage of research, it seems that the beneficial properties of various probiotics 
used in animal nutrition are strain-dependent. Hence, attention is paid so that they are 
strictly defined. Each requires a separate set of tests in order to determine their probiotic 
properties (FAO/WHO, 2002).  
The aim of our research was to design and evaluate the effectiveness of a probiotic 
preparation intended for poultry. The basis of this preparation are bacteria of the genus 
Lactobacillus: Lactobacillus paracasei ŁOCK 0920, Lactobacillus brevis ŁOCK 0944, Lactobacillus 
plantarum ŁOCK 0945 (Michałowski et al., 2004). Strains were characterized for their 
probiotic properties (Motyl, 2002; Motyl & Klewicka unpublished data, 2003). The study 
determined, among others, the resistance of the tested strains to low pH, the ability to 
adhere to intestinal epithelial cells and the antagonistic activity of these strains in relation to 
pathogenic strains that cause food poisonings and disease states in animals.  
All tested cultures of Lactobacillus sp. showed a strong activity in respect of inhibiting the 
growth of both Gram-negative pathogenic strains (Pseudomonas aeruginosa, Escherichia coli, 
Salmonella Typhimurium, Salmonella Enteritidis, Shigella sonnei) and Gram-positive 
pathogenic strains (Staphylococcus aureus, Enterococcus faecalis, Listeria monocytogenes, Listeria 
innocua). It is worth noting that Pseudomonas aeruginosa bacteria were inhibited in the 
strongest way, and Enterococcus faecalis bacteria were inhibited with the weakest 
effectiveness (Table 1). 
Due to the different sensitivity of various pathogenic bacteria to the metabolites of probiotic 
strains, it seems reasonable to use in animal feeding probiotic preparations made as a 
composition of different strains, which is consistent with literature data (Mountzouris et al., 
2007).  
4.2 Detoxification of mycotoxins 
Mycotoxins are toxic secondary metabolites of fungi mainly belonging to the genera 
Aspergillus sp., Penicillium sp. and Fusarium sp. Chemically, they are enumerated among 
aromatic hydrocarbons (sometimes among aliphatic ones) with low molecular weight, 
which determines their resistance to environmental factors and the absence of or weak 
immunogenic properties (Gajęcki, 2002). The most important among the mycotoxins, from 
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The pathogenic strain 
The antagonistic strain 
Lactobacillus paracasei 
ŁOCK 0920 
Lactobacillus plantarum 
ŁOCK 0945 
Lactobacillus 
brevis 
ŁOCK 0944 
Inhibitor zone (mm) 
Pseudomonas aeruginosa 
ATCC 27853 
18.0 9.0 19.5 
Staphylococcus aureus 
ATCC 25923 
14.0 9.5 12.5 
Escherichia coli 
ATCC 25922 
13.5 11.5 25.5 
Escherichia coli 
ŁOCK 0836 12.0 9.0 21.5 
Escherichia coli 018 13.0 11.0 21.0 
Salmonella Enteritidis 14.0 9.0 8.0 
Salmonella Typhimurium 9.0 10.0 7.0 
Shigella sonnei 9.0 7.0 7.0 
Listeria monocytogenes 12.0 14.0 12.5 
Listeria innocua 11.0 12.0 10.0 
Enterococcus faecalis 8.0 9.0 7.5 
Table 1. Antagonistic activity of Lactobacillus in relation to microbial food-borne pathogens 
expressed as a zone of growth inhibition in mm (according to Motyl, 2002; Motyl & 
Klewicka unpublished data, 2003). 
the toxicological point of view and also taking into account the etiology of some animal 
diseases are: aflatoxins (AFB1, AFB2, AFG1, AFG2), ochratoxins (OTA and OTB), 
trichothecenes (DON, NIV, T-2, HT-2, DAS), zearalenone (F-2) and fumonisins (FB1, FB2, 
FB3) . The synthesis of mycotoxins by fungi is genetically conditioned, but it is determined 
by environmental factors, which include: substrate composition, its texture, moisture, 
temperature and the presence of competitive microflora (Gourama & Bullerman, 1995; 
Batish et al., 1997; Fink-Gremmels, 1999). The invasion of mycotoxins into the body of 
animals takes place mainly via food, and the health effects, called mycotoxicoses, are 
poisonings with various courses - acute or chronic - resulting from the receiving small doses 
for a long time (Yiannikouris & Jouany, 2002). Due to the specific chemical and physical 
properties of mycotoxins, the spectrum of their activities in the body of animals is very 
different and it is characteristic for the groups of these metabolites. First of all, mycotoxins 
have a specific effect on the groups of body tissues (epithelia, nervous system tissue, 
secretory organs tissue - the pancreas, liver, kidney tissue, etc.), including the individual 
cells.  By interfering with metabolic pathways, they may lead to abnormal replication of the 
cell’s genetic code, which impairs the process of tissue proteins reconstruction (including the 
immune system – proteins of antibodies). They also damage and disrupt transport 
mechanisms in the cytoplasm of cells and between cells, block enzymatic reactions of cells, 
especially in mitochondria, as well as within cells. In addition, they may block co-factors of 
metabolic reactions, such as some vitamins. A significant adverse influence of numerous 
mycotoxins has also been confirmed (in particular of OTA, AFB1, DON and T-2) on the 
antioxidant components of cells and tissues, indicating at the same time this process as on 
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the most dangerous for the organism’s equilibrium and the occurrence of 
immunosuppression and oxidative stress (Sharma, 1993; Benett & Klich, 2003).  
According to the current knowledge (Huwing et al., 2001; Diaz et al., 2004), removal of 
toxins from grains and feed can be carried out by mechanical separation of contaminated 
grains (sorting), addition of adsorptive materials, and using the activity of physical, 
chemical and biological factors.  
Among the many microbes that show the potential for detoxification, special interest is 
aroused by lactic acid bacteria and yeasts (Shetty & Jespersen, 2006). Initial studies have 
shown that different strains of lactic acid bacteria can inhibit the biosynthesis of aflatoxins 
(Coallier-Ascah & Idziak, 1985). The concept of using yeasts to remove mycotoxins during 
fermentation processes appeared in the studies conducted by Benneta et al. (1981), who used 
corn contaminated by zearalenone as a substrate for alcohol production with the 
participation of yeasts of the genus Saccharomyces.  
Literature data shows that apart from common lactic bacteria there appear varieties with 
different abilities to detoxify the environments from mycotoxins (Oatley, 2000). The research 
of EL-Nezami et al. (1996, 1998, 2000 a and b) proves that these properties are manifested by 
strains of Lactobacillus rhamnosus (LBGG and LC705). Ŝtyriak et al. (2001), examined the 
ability of 10 yeast strains of the genus Saccharomyces, Kluyveromyces and Rhodotorula to 
detoxify fumonisin B1, toxin T-2 and ochratoxin A. Out of the tested organisms, yeasts of the 
genus Saccharomyces were characterized with the greatest predispositions in the area in 
question.  
The research on the abilities of probiotic preparations for poultry manifested in the area of 
biological detoxification of mycotoxins, carried out under in vitro conditions (Biernasiak et 
al., 2006), showed that after six hours of incubation, the loss of aflatoxins in the control 
sample of feed, where there was no process of fermentation, equaled from 28 to 30%, and in 
case of ochratixin A it equaled from 8 to 10%. After twenty-four hours of incubation of the 
control sample with the addition of [5 µg/kg] ochratoxin A, a further loss was noted which 
equaled 10%, and 2% for the medium with the addition of [50 µg/kg]. The concentration of 
aflatoxins increased from 5 to 10%, probably as a result of desorption (Figure 2). 
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Fig. 2. Reduction of aflatoxins and ochratoxin A concentration in the sample without 
fermentation 
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After six hours of fermentation with the addition of probiotic cultures, the quantity of 
aflatoxins was reduced by 18 to 33% compared to that recorded in the control sample, 
and as for ochratoxin A the reduction equaled from 29 to 49%. After the fermentation, the 
loss of ochratoxin A, both at a low concentration, namely 5 µg/kg, and at a high 
concentration, namely 50 µg/kg, was at a similar level and equaled 50%. The same 
relationship was also noted for low levels of aflatoxins, i.e. for 4 µg/kg inserted into the 
fermentation medium. At high concentration, i.e. 40 µg/kg, the loss of aflatoxins was lower 
and amounted to about 30% (Figure 3). 
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Fig. 3. Reduction of aflatoxins and ochratoxin A concentration during fermentation with the 
use of probiotic bacteria and yeasts 
During a spontaneous fermentation, the loss of mycotoxins was much lower, and after six 
hours of fermentation a decrease was observed by 6–8% in the concentration of aflatoxins in 
relation to the initial concentration recorded in the control sample, and for ochratoxin A the 
decrease equaled to from 12 to 19%. After the fermentation, the loss of both aflatoxins and 
ochratoxin A was at a similar level from 16-24% compared with the medium in which no 
fermentation occurred (Figure 4). It was found that the probiotic vaccine creates a probiotic 
starter culture endowed with a stable feature of detoxification of mycotoxins, and 
particularly ochratoxin A. 
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Fig. 4. Reduction of aflatoxins and ochratoxin A concentration during spontaneous fermentation 
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İliĽewska (unpublished data) examined the ability of a probiotic preparation to counteract 
the deleterious effects of aflatoxin B1 (AFB1) in broiler chickens (in vivo experiments). The 
probiotic preparation used contained (per 1 kg): 1010 of Lactobacillus cells (L. paracasei LOCK 
0920, L. brevis LOCK 0944 and L. plantarum LOCK 0945), 106 of yeast Saccharomyces cerevisiae 
LOCK 0140 cells and 50g of Yucca schidigera extract. The Ross broiler chicks from a 
commercial hatchery were used in this study. The chickens were divided into four 
experimental groups depending on the feed administered to them: fed with the feed 
contaminated with 1 or 5 mg of AFB1 per kg, and fed with the feed contaminated with AFB1 
and supplemented with the probiotic preparation. The amount of aflatoxin B1 in the feces 
was determined for each week of rearing in 10 chickens in each group. After 35 days (of 
rearing) chickens were slaughtered and the concentration of toxins in the liver and kidneys 
was determined.  The histopathological changes were evaluated in tissue sections obtained 
from the liver and kidneys of the tested animals. 
The research showed that the presence of probiotics in the feed resulted in a statistically 
significant increase in the quantity of aflatoxin B1 excreted in the feces of the chickens. At the 
end of breeding, i.e. on the 35th day, in the feces of chickens consuming feed contaminated 
with aflatoxin B1 (at a concentration of 1 or 5 mg/kg) and containing the probiotic 
preparation, the content of toxins was higher by 67% and 31% compared to the feces of 
chickens consuming feed without the probiotic. The addition of the probiotic preparation 
prevented the accumulation of toxins in the organs (liver and kidneys) in the extent 
observed in the case of chickens consuming feed without the probiotic (Table 2). The toxins 
were not accumulated in the organs in such large amounts as in the case of chickens 
consuming feed without probiotics, and they were excreted to a greater extent in the feces.  
 
Test group 
 
 
1mg/kg 
AFB1 
1mg/kg AFB1 
+probiotic 
5mg/kg 
AFB1 
5mg/kg AFB1 
+probiotic 
 Concentration of aflatoxin B1 [µg/kg]  
Feces 
Range 
Mean* 
0.21 - 0.47 
0.29 (± 0.10)a 
0.52 - 1.25 
0.89 (± 0.30)b 
2.52 - 2.88 
2.74 (± 0.13)c 
3.68 - 7.50 
4.00 (± 1.61)d 
Liver 
Range 
Mean* 
8.30 - 9.64 
8.86 (± 0.49)a 
2.10 - 4.52 
3.69 (± 0.95)b 
8.42 - 14.84 
11.84 (± 2.99)c 
3.52 - 7.20 
5.88 (± 1.69)d 
Kidneys 
Range 
Mean* 
4.60 - 11.62 
7.93 (± 2.91)a 
1.24 - 3.60 
2.55 (± 0.96)b 
10.10 - 17.16 
13.71 (± 2.76)c 
2.94 - 4.62 
4.06 (± 0.68)d 
* Results are presented as an arithmetic mean (± standard deviation) 
ab Values in rows denoted with different letters differ considerably for P<0.05 
Table 2. Concentration of  aflatoxin B1 in the feces, liver and kidneys 
Pathological changes were observed in the livers of chickens consuming the feed  
contaminated with aflatoxin B1 at both concentrations (1 and 5 mg/kg of feed). The changes 
were similar in type (fibrosis of the portal area and liver parenchyma, eosinophil infiltrates 
in the portal area, steatosis of hepatocytes), but the changes in the livers of chickens 
consuming the feed contaminated with aflatoxin B1 and supplemented with probiotics were 
slightly less severe. The strongest toxic changes were found in the group of chickens 
consuming the feed contaminated with aflatoxin B1 at 5 mg/kg of feed (Figure 5). These 
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changes revealed the characteristics of micronodular cirrhosis with very severe eosinophil 
infiltrates.  
 
  
(a)                                                                      (b) 
(a) Eosinophil infiltrates and enlarged lymphatic node  (b) Eosinophil infiltrates 
Fig. 5. Histological changes in the liver of chickens fed with the feed contaminated with 
AFB1 (a) and supplemented with a probiotic preparation (b).  
Kidney damage was found only in the chickens consuming the feed contaminated with 5 
mg/kg of aflatoxin B1; however, in the chickens consuming the feed with probiotics, the 
intensity of the changes was smaller. The changes concerned enlargement of renal glomeruli 
and an increase of mezangium matrix and cells (Figure 6).  
While supplementation of feed with the probiotic preparation does not constitute protection 
against pathological changes in organs, it reduces the changes primarily in the kidneys. 
 
   
(a)     (b) 
(a) Gromeruli diameter – 200-400 m (b) Gromeruli diameter – 150-200 m 
Fig. 6. Histological changes in kidneys of the chickens fed with the feed contaminated with 
AFB1 (a) and supplemented with probiotic preparation (b).  
4.3 The immunological system stimulation 
The microbes of intestinal microflora are the main factor stimulating the immune system, 
which is a prerequisite for the development of lymphoid structures of the system 
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(laboratory animals born and kept in sterile conditions do not develop them). 
Immunomodulating effect of intestinal microflora, including that of probiotic bacteria is 
based on three seemingly contradictory phenomena (Dugas et al., 1999; Isolauri et al., 2001):  
 induction and maintenance of immune tolerance to environmental antigens (food and 
inhalants) 
 induction and control of immune responses against pathogens of bacterial and viral 
origin 
 inhibition of autoimmune and allergic reactions. 
For example, in the case of chickens, GALT (gut-associated lymphoid tissue) reaches full 
maturity after two weeks since hatching (Bar–Shira et al., 2003). Until then, in the 
gastrointestinal immune system there are T and B cells, macrophages and NK cells (Lillehoj  
& Trout, 1996). The aim of the research conducted by Haghighi et al. (2006), was to 
determine the effect of probiotic bacteria on the increase of natural antibodies (IgA, IgG and 
IgM) in the intestinal content and blood serum of chickens. The chickens were divided into 
two groups. Group I was administered to the beak 0.5 ml of PBS buffer containing 106 of 
bacteria, namely Lactobacillus acidophilus, Bifidobacterium bifidum and Enterococcus faecalis, 
while Group II received 0.5 of PBS buffer without additives (control group). It was 
demonstrated that the intestinal content of the chickens receiving the probiotic, compared 
with the control group, had increased level of IgA antibodies (P < 0.001), reactive against the 
tetanus toxin (TT), alpha-toxin of Clostridium perfringns and bovine serum albumin (BSA). 
Similar relationships were recorded in relation to IgG antibodies, but they were reactive 
only to TT. The serum of the chickens treated with the probiotic showed an increased level 
of IgG antibodies (P ≤ 0.05), but they were reactive only to TT and alfa–toxin. Similar 
dependencies (P ≤ 0.01) were noted for IgM antibodies. 
5. Effects of the application of probiotics in animal nutrition 
The earliest from of probiotics, still widely used in animal nutrition, was based on silage, 
whose usefulness has been proven by many years of use. Modern probiotic preparations 
must be subjected to comprehensive testing in accordance with Commission Directive 
94/40/EC of 22 July 1994 setting out procedures for the assessment of additives in animal 
nutrition.  
The usefulness of probiotics in the nutrition of young pigs has been shown, although the 
results varied greatly from one another especially in relation to such indicators of 
production as growth and feed efficiency (Turner et al., 2002). The outcome of most studies 
indicate the beneficial effect of probiotics on the health of piglets. The most frequently 
observed effect is a reduction in the incidence rate of diarrhea and shortening of its 
duration, as well as a decrease in the mortality rate of piglets during the pre-weaning and 
peri-weaning period (Ross et al., 2008 & 2010). It was demonstrated that the best results are 
obtained when the probiotic is administered already on the first, or on the second day of life 
at the latest. That is why probiotics are administered to them after birth orally in the form of 
a special paste with the use of special dispensers (Janik et al., 2006). Literature reports on the 
effects of the application of probiotics in case of chickens are mixed, similarly to those 
referring to pigs.  
The study conducted by Smulikowska et al., (2005) demonstrated that feeding broiler 
chickens with the feed supplemented with a probiotic preparation LABYuc-Probio 
(containing in 1g: 4.7×107 of Lactobacillus bacteria, 2.0×103 of Saccharomyces cerevisiae yeasts 
www.intechopen.com
 Feeds with Probiotics in Animals’ Nutrition 
 
193 
and 50 mg of Yucca schidigera extract) did not result in significant changes in the body 
weight gains and feed utilization compared with a group of chickens receiving antibiotic 
feed with or without any additions.  
Similar relationships were obtained in studies conducted by Watkins & Kratzer, (1983 & 
1984) and Maiolino et al., (1992). However, in a group of chickens receiving a mixture 
supplemented with a probiotic preparation, the body mass of birds in different periods of 
rearing was the most uniform, as evidenced by lower standard deviation (SD). It was found 
that, regardless of the use of a probiotic feed additive, an antibiotic, or the total lack of 
supplements, the relative weights of liver, pancreas, abdominal fat and the individual 
sections of the gastrointestinal tract converted to % of the chickens’ body weights before 
slaughter were similar and statistically insignificant. The research by Jin et al. (1998), 
showed that addition to the chickens’ diet of L. acidophilus or a mix of bacteria of the genus 
Lactobacillus, namely L. acidophilus (2), L. fermentum (3), L. crispatus (1) and L. brevis (6), had 
no  statistically significant effect either on the weight of the crop, liver, spleen, duodenum 
and small intestine expressed as % of the body weight of chickens prior to slaughter. Similar 
dependencies were also obtained in the studies of Fethiere & Miles, (1987) and Watkins & 
Kratzer, (1984).  
In addition, our own study (Biernasiak et al., 2009) showed that supplementing feed with a 
probiotic preparation LABYuc-Probio® already during the first week of rearing resulted in a 
significant reduction in the number of bacteria of the genus Clostridium in the fecal-urate 
excreta of chickens. The number of these bacteria was about 105 CFU/g, while in the fecal-
urate excreta of broiler chickens fed with the feed supplemented with an antibiotic or the 
feed without any additives it was higher by about two orders of magnitude. After the 
second week of rearing, regardless of the type of feed supplementation, there was noted a 
decrease by one order of magnitude in the number of bacteria of the genus Clostridium. After 
the third week of rearing, the further reduction in the number of bacteria of the genus 
Clostridium was observed, but only in the fecal-urate excreta of broiler chickens feed with the 
feed supplemented with the probiotic preparation. The number of bacteria then equaled 
around 103 CFU/g and it was lower by three orders of magnitude compared to that 
recorded in the fecal-urate excreta of the chickens included into the two remaining groups. 
After the fourth week of rearing, depending on the type of feed supplementation, a 
differentiation of the number of bacteria was observed; from 104 CFU/g to 105 CFU/g. 
Nevertheless, it must be emphasized that still the lowest number (104 CFU/g) of the studied 
microorganisms was recorded in the fecal-urate excreta of birds fed with the feed 
supplemented with the probiotic preparation. After the fifth and sixth week of rearing, the 
number of bacteria of the genus Clostridium in the fecal-urate excreta of broilers fed with the 
feed with the probiotic or without additional supplements was at the same level and 
amounted to approximately 105 CFU/g. The birds receiving the feed with antibiotics, 
compared with the other two, still manifested a higher number of these bacteria, by 
respectively, two orders of magnitude, and one order of magnitude (Figure 7). Analysis of 
variance Anova showed statistically significant differences between the kind of feed 
supplementation, and the number of bacteria of the genus Clostridium in the fecal-urate 
excreta of chickens in the period from the second to the fifth week of rearing (0.01<p<0.05). 
The obtained results are particularly important in view if the fact that after the withdrawal 
of antibiotic growth promoters from poultry feed mixtures an increase may be expected in 
the incidence of intestinal problems, especially related to Clostridium perfringens, i.e. necrotic 
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enteritis (NE). In France, the occurrence of NE increased from 4.0% in 1995 to 12.4% in 1999 
and similar dependencies were also observed in other European countries (Lipiński, 2007). 
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Fig. 7. Bacteria of the genus Clostridium in the feces of chickens 
Supplementing the feed with the probiotic preparation LABYuc-Probio® also contributed to 
the stabilization of the number of Enterobacteriaceae, including bacteria from the coli group in 
the chickens’ fecal-urate excreta during individual weeks of rearing (Figure 8).  
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Fig. 8. Total number of bacteria of the coli group in the feces of chickens 
Kralik et al. (2004) recorded a decrease in the number of Enterobacteriaceae and bacteria of the 
coli group by about 90%, compared to the control  group, i.e. 1.39106 and 2.72105 CFU/g 
after 42 days of supplementing water with a probiotic containing 5109 CFU/g of 
Enterococcus faecium M-74. However, he did not find statistically significant differences in the 
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number of bacteria of the genera Staphylococcus sp., Bacillus sp. and Clostridium sp. Jin et al., 
(1998) showed that the addition of L. acidophilus or a mixture of bacteria of the genus 
Lactobacillus into the chickens’ diet had a statistically significant effect (P<0.05) on the 
decrease in the number of bacteria of the coli group in the blind gut, compared to the control 
sample, but only on the 10th and 20th day of rearing. At the same time, he registered no 
similar changes in the small intestine.  
An average number of bacteria of the genus Lactobacillus in the fecal-urate excreta of all 
studied groups of chickens during individual weeks of rearing equaled from 109 to 1010 
CFU/g (Figure 9). Data analysis showed that only after the third week of rearing there were 
recorded statistically significant differences (p<0.01) between the type of feed additive, and 
the number of bacteria of the genus Lactobacillus found in the birds’ fecal-urate excreta 
(Biernasiak & Slizewska, 2009). The research of Jin et al., (1998) demonstrated that 
supplementation with L. acidophilus or a mixture of bacteria of the genus Lactobacillus did not 
have an influence on the statistically significant increase in the number of bacteria of the 
genus Lactobacillus in the blind gut during the individual weeks of rearing, and in case of the 
small intestine significant changes were recorded only on the 30th day of rearing. Similarly, 
the research of Watkins & Kratzer (1983, 1984) found no significant increase in the number 
of bacteria of the genus Lactobacillus sp. in the chickens’ intestines. 
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Fig. 9. Bacteria of the genus Lactobacillus in the feces of chickens 
While using a probiotic preparation consisting of Bacillus subtillis CH201 and Bacillus 
licheniformis CH200 in the feed for laying hens, a statistically significant decrease was noted 
(P<0.05) as for the content of cholesterol and triglycerides in the serum and egg yolk. 
However, no statistically significant increase in the feed efficiency, egg production, or the 
impact on the thickness and hardness of the shell was demonstrated (Mahdari et al., 2005). 
On the other hand, the application of Enterococcus faecium M-74 in the feed for laying hens 
resulted in obtaining eggs with thicker and more breakage-resistant shells and in a more 
intense color of the yolk (Angelovicova, 1996). 
It should be emphasized that the results presented above represent only a fraction of 
worldwide research. The divergence of the results in the presented cases indicates the need 
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for further research in order to clarify the questionable effects of probiotics in animal 
nutrition. 
The future of probiotics involves aspiring to reach full explanation of mechanisms 
concerning their activity in relation to mutual microorganism-animal interaction and 
looking for new bacterial strains, as well. Delimitation of appropriate directions of research 
can have a great meaning for newly described principles of prophylaxis in animal nutrition 
without using antibiotic growth stimulators.  
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